Elevated alpha-foetoprotein and hepatic metastases--it's not always what it seems!
Gastric cancers that secrete alpha-foetoprotein (AFP) are a rare but well defined entity. These tumours tend to be aggressive with a poor prognosis. Recognition and identification of this group of patients is important in influencing prognosis, treatment options and further clinical research into this entity. We report three cases of gastric cancers associated with elevated AFP. This entity should be considered in patients with hepatic lesions and an elevated AFP without risk factors for hepatocellular carcinoma or in patients with associated gastric symptoms.
Marx
G M
GM
Prince of Wales Hospital, Randwick, Sydney, Australia. gavin.marx@kcl.ac.uk
Boyce
A
A
Goldstein
D
D
D000368:Aged; D006801:Humans; D008113:Liver Neoplasms / Q000097:blood* / Q000175:diagnosis* / Q000556:secondary; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D013274:Stomach Neoplasms / Q000097:blood* / Q000175:diagnosis* / Q000473:pathology; D013997:Time Factors; D000509:alpha-Fetoproteins / Q000032:analysis* / Q000378:metabolism
D000509:alpha-Fetoproteins